Journal Article
. 2019 Aug; 129(9):3952-3962.
doi: 10.1172/JCI128437.

Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways

Polina Weitzenfeld  Stylianos Bournazos  Jeffrey V Ravetch  
  • PMID: 31424423
  •     53 References
  •     16 citations


Sialyl Lewis A (sLeA, also known as CA19-9), a tetrasaccharide selectively and highly expressed on advanced adenocarcinomas including colon, stomach, and pancreatic cancers, has long been considered as an attractive target for active and passive vaccination. While progress in antibodies targeting tumor-associated protein antigens resulted in an impressive array of therapeutics for cancer treatment, similar progress in exploiting tumor-associated carbohydrate antigens, such as sLeA, has been hampered by the lack of a detailed understanding of the singular characteristics of these antigens. We have addressed this issue by analyzing antibodies derived from patients immunized with an sLeA/KLH vaccine. These antibodies were engineered to mediate tumor clearance in vivo in preclinical models through Fc-FcγR interactions. However, in contrast to protein antigens in which hFcγRIIIA engagement was both necessary and sufficient to mediate tumor clearance in both preclinical and clinical settings, a similar selective dependence was not seen for anti-sLeA antibodies. Thus, re-engineering the Fc portion of sLeA-targeting antibodies to broadly enhance their affinity for activating FcγRs led to an enhanced therapeutic effect. These findings will facilitate the development of more efficient anticancer therapies and further advance this promising class of therapeutic antibodies into clinical use.

Keywords: Cancer immunotherapy; Immunoglobulins; Immunology.

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.
R A Clynes, T L Towers, L G Presta, J V Ravetch.
Nat Med, 2000 Mar 31; 6(4). PMID: 10742152
Highly Cited.
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.
Guillaume Cartron, Laurent Dacheux, +4 authors, Hervé Watier.
Blood, 2002 Jan 25; 99(3). PMID: 11806974
Highly Cited.
Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
Maciej Ugorski, Anna Laskowska.
Acta Biochim Pol, 2002 Oct 05; 49(2). PMID: 12362971
Sialyl Lewisa expression as a predictor of the prognosis of colon carcinoma patients in a prospective randomized clinical trial.
Takanori Matsui, Hiroshi Kojima, +5 authors, Junichi Sakamoto.
Jpn J Clin Oncol, 2004 Dec 14; 34(10). PMID: 15591456
Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Udo Jeschke, Ioannis Mylonas, +4 authors, Klaus Friese.
Anticancer Res, 2005 Jul 22; 25(3A). PMID: 16033070
FcgammaRIV: a novel FcR with distinct IgG subclass specificity.
Falk Nimmerjahn, Pierre Bruhns, Ken Horiuchi, Jeffrey V Ravetch.
Immunity, 2005 Jul 26; 23(1). PMID: 16039578
Highly Cited.
Divergent immunoglobulin g subclass activity through selective Fc receptor binding.
Falk Nimmerjahn, Jeffrey V Ravetch.
Science, 2005 Dec 03; 310(5753). PMID: 16322460
Highly Cited.
Engineered antibody Fc variants with enhanced effector function.
Greg A Lazar, Wei Dang, +11 authors, Bassil I Dahiyat.
Proc Natl Acad Sci U S A, 2006 Mar 16; 103(11). PMID: 16537476    Free PMC article.
Highly Cited.
Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A.
A Takada, K Ohmori, +5 authors, R Kannagi.
Biochem Biophys Res Commun, 1991 Sep 16; 179(2). PMID: 1716885
Highly Cited.
Antibodies, Fc receptors and cancer.
Falk Nimmerjahn, Jeffrey V Ravetch.
Curr Opin Immunol, 2007 Feb 13; 19(2). PMID: 17291742
Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression.
Reiji Kannagi.
Chang Gung Med J, 2007 Sep 01; 30(3). PMID: 17760270
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.
Antonino Musolino, Nadia Naldi, +9 authors, Andrea Ardizzoni.
J Clin Oncol, 2008 Mar 19; 26(11). PMID: 18347005
Highly Cited.
Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells.
John O Richards, Sher Karki, +3 authors, John R Desjarlais.
Mol Cancer Ther, 2008 Aug 30; 7(8). PMID: 18723496
Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions.
Lucie Baudino, Yasuro Shinohara, +7 authors, Shozo Izui.
J Immunol, 2008 Oct 23; 181(9). PMID: 18941257
Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies.
Dipa Patel, Rajiv Bassi, +4 authors, Xiaoqiang Kang.
Anticancer Res, 2008 Nov 28; 28(5A). PMID: 19035294
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response.
Riad Abès, Emmanuelle Gélizé, Wolf Herman Fridman, Jean-Luc Teillaud.
Blood, 2010 May 05; 116(6). PMID: 20439625
FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.
Falk Nimmerjahn, Anja Lux, +5 authors, Jeffrey V Ravetch.
Proc Natl Acad Sci U S A, 2010 Oct 27; 107(45). PMID: 20974962    Free PMC article.
Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity.
Ritsuko Sawada, Shu-Man Sun, +4 authors, Wolfgang W Scholz.
Clin Cancer Res, 2011 Feb 24; 17(5). PMID: 21343375    Free PMC article.
Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies.
Fubin Li, Jeffrey V Ravetch.
Science, 2011 Aug 20; 333(6045). PMID: 21852502    Free PMC article.
Highly Cited.
Glycans as cancer biomarkers.
Barbara Adamczyk, Tharmala Tharmalingam, Pauline M Rudd.
Biochim Biophys Acta, 2011 Dec 20; 1820(9). PMID: 22178561
Highly Cited. Review.
Antibody therapy of cancer.
Andrew M Scott, Jedd D Wolchok, Lloyd J Old.
Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437872
Highly Cited. Review.
Mouse model recapitulating human Fcγ receptor structural and functional diversity.
Patrick Smith, David J DiLillo, +2 authors, Jeffrey V Ravetch.
Proc Natl Acad Sci U S A, 2012 Apr 05; 109(16). PMID: 22474370    Free PMC article.
Highly Cited.
Properties of mouse and human IgG receptors and their contribution to disease models.
Pierre Bruhns.
Blood, 2012 Apr 27; 119(24). PMID: 22535666
Highly Cited. Review.
Marketing approval of mogamulizumab: a triumph for glyco-engineering.
Alain Beck, Janice M Reichert.
MAbs, 2012 Jun 16; 4(4). PMID: 22699226    Free PMC article.
Translating basic mechanisms of IgG effector activity into next generation cancer therapies.
Falk Nimmerjahn, Jeffrey V Ravetch.
Cancer Immun, 2012 Aug 17; 12. PMID: 22896758    Free PMC article.
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer.
James D Mellor, Michael P Brown, +2 authors, Alexander Dobrovic.
J Hematol Oncol, 2013 Jan 05; 6. PMID: 23286345    Free PMC article.
Highly Cited. Review.
The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.
Katherine E Poruk, D Z Gay, +5 authors, S J Mulvihill.
Curr Mol Med, 2013 Jan 22; 13(3). PMID: 23331006    Free PMC article.
Highly Cited. Review.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Expression of carbohydrate-antigen sialyl-Lewis a on colon cancer cells promotes xenograft growth and angiogenesis in nude mice.
Laura Terraneo, Laura Avagliano, +5 authors, Marco Trinchera.
Int J Biochem Cell Biol, 2013 Oct 17; 45(12). PMID: 24128856
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.
Mahiuddin Ahmed, Nai-Kong V Cheung.
FEBS Lett, 2013 Dec 04; 588(2). PMID: 24295643
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.
Holbrook E Kohrt, Ariane Thielens, +14 authors, Pascale André.
Blood, 2013 Dec 12; 123(5). PMID: 24326534    Free PMC article.
Highly Cited.
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.
Valentin Goede, Kirsten Fischer, +20 authors, Michael Hallek.
N Engl J Med, 2014 Jan 10; 370(12). PMID: 24401022
Highly Cited.
Type I and type II Fc receptors regulate innate and adaptive immunity.
Andrew Pincetic, Stylianos Bournazos, +5 authors, Jeffrey V Ravetch.
Nat Immunol, 2014 Jul 22; 15(8). PMID: 25045879    Free PMC article.
Highly Cited. Review.
Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
V I Seledtsov, A G Goncharov, G V Seledtsova.
Hum Vaccin Immunother, 2015 May 02; 11(4). PMID: 25933181    Free PMC article.
Dinutuximab: first global approval.
Sohita Dhillon.
Drugs, 2015 May 06; 75(8). PMID: 25940913
Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect.
David J DiLillo, Jeffrey V Ravetch.
Cell, 2015 May 16; 161(5). PMID: 25976835    Free PMC article.
Highly Cited.
Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions.
David J DiLillo, Jeffrey V Ravetch.
Cancer Immunol Res, 2015 Jul 04; 3(7). PMID: 26138698
Highly Cited. Review.
Obinutuzumab in hematologic malignancies: lessons learned to date.
Tim Illidge, Christian Klein, +3 authors, Guillaume Cartron.
Cancer Treat Rev, 2015 Jul 21; 41(9). PMID: 26190254
Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis.
Nat Rev Cancer, 2015 Aug 21; 15(9). PMID: 26289314
Highly Cited. Review.
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.
Rony Dahan, Emanuela Sega, +3 authors, Jeffrey V Ravetch.
Cancer Cell, 2015 Sep 17; 28(3). PMID: 26373277
Highly Cited.
Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
Yong-xi Song, Xuan-zhang Huang, +7 authors, Zhen-ning Wang.
Dis Markers, 2015 Nov 18; 2015. PMID: 26576068    Free PMC article.
A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors.
Daniela Kao, Heike Danzer, +6 authors, Falk Nimmerjahn.
Cell Rep, 2015 Dec 17; 13(11). PMID: 26670049
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential.
Gregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio.
Ther Adv Med Oncol, 2016 Jan 12; 8(1). PMID: 26753003    Free PMC article.
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement.
Rony Dahan, Bryan C Barnhart, +3 authors, Jeffrey V Ravetch.
Cancer Cell, 2016 Jun 07; 29(6). PMID: 27265505    Free PMC article.
Highly Cited.
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.
Stylianos Bournazos, Anna Gazumyan, +2 authors, Jeffrey V Ravetch.
Cell, 2016 Jun 18; 165(7). PMID: 27315478    Free PMC article.
Highly Cited.
Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
Jacob L Houghton, Rosemery Membreno, +6 authors, Brian M Zeglis.
Mol Cancer Ther, 2017 Jan 08; 16(1). PMID: 28062708    Free PMC article.
Highly Cited.
Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with 89Zr-5B1.
Jacob L Houghton, Dalya Abdel-Atti, Wolfgang W Scholz, Jason S Lewis.
Mol Pharm, 2017 Feb 14; 14(3). PMID: 28191976    Free PMC article.
Diversification of IgG effector functions.
Stylianos Bournazos, Jeffrey V Ravetch.
Int Immunol, 2017 May 05; 29(7). PMID: 28472280    Free PMC article.
Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma.
Sophie Poty, Lukas M Carter, +6 authors, Jason S Lewis.
Clin Cancer Res, 2018 Oct 26; 25(2). PMID: 30352909    Free PMC article.
Significance of 2-3 and 2-6 sialylation of Lewis a antigen in pancreas cancer.
S Itai, S Arii, +7 authors, R Kannagi.
Cancer, 1988 Feb 15; 61(4). PMID: 3422178
Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium.
A Takada, K Ohmori, +4 authors, R Kannagi.
Cancer Res, 1993 Jan 15; 53(2). PMID: 7678075
Highly Cited.
Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma.
T Nakayama, M Watanabe, +2 authors, M Kitajima.
Cancer, 1995 Apr 15; 75(8). PMID: 7697593
Possible roles of tumor-associated carbohydrate antigens.
M Fukuda.
Cancer Res, 1996 May 15; 56(10). PMID: 8625291
Highly Cited. Review.
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory.
Wenhao Luo, Gang Yang, +8 authors, Taiping Zhang.
Cancer Cell Int, 2020 Mar 12; 20. PMID: 32158356    Free PMC article.
A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques.
Koen K A Van Rompay, Lark L Coffey, +23 authors, Davide F Robbiani.
Proc Natl Acad Sci U S A, 2020 Mar 27; 117(14). PMID: 32209664    Free PMC article.
FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies.
Sara Borghi, Stylianos Bournazos, +9 authors, Taia T Wang.
Proc Natl Acad Sci U S A, 2020 May 29; 117(23). PMID: 32461366    Free PMC article.
Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale Towards A Personalized Clinical Application.
Rossella Indellicato, Aida Zulueta, Anna Caretti, Marco Trinchera.
Cancers (Basel), 2020 Jun 13; 12(6). PMID: 32527016    Free PMC article.
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection.
Stylianos Bournazos, Davide Corti, Herbert W Virgin, Jeffrey V Ravetch.
Nature, 2020 Oct 09; 588(7838). PMID: 33032297    Free PMC article.
Carbohydrate antigen 19-9 - tumor marker: Past, present, and future.
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat.
World J Gastrointest Surg, 2021 Jan 14; 12(12). PMID: 33437400    Free PMC article.
Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.
Xing Huang, Gang Zhang, Tianyu Tang, Tingbo Liang.
Mol Cancer, 2021 Mar 03; 20(1). PMID: 33648511    Free PMC article.
Fc-engineered antibody therapeutics with improved efficacy against COVID-19.
Rachel Yamin, Andrew T Jones, +7 authors, Stylianos Bournazos.
Res Sq, 2021 Jun 03;. PMID: 34075373    Free PMC article.
Tackling COVID-19 with neutralizing monoclonal antibodies.
Davide Corti, Lisa A Purcell, Gyorgy Snell, David Veesler.
Cell, 2021 Jun 05; 184(12). PMID: 34087172    Free PMC article.
Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment.
Rani Chudasama, Quan Phung, Andrew Hsu, Khaldoun Almhanna.
Vaccines (Basel), 2021 Jul 03; 9(6). PMID: 34199248    Free PMC article.
Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.
Itziar Ibarlucea-Benitez, Polina Weitzenfeld, Patrick Smith, Jeffrey V Ravetch.
Proc Natl Acad Sci U S A, 2021 Jun 23; 118(26). PMID: 34155121    Free PMC article.
Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.
Magdalena Thurin.
Monoclon Antib Immunodiagn Immunother, 2021 Jun 24; 40(3). PMID: 34161162    Free PMC article.
Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects.
Dhuha H Nawab.
Hum Vaccin Immunother, 2021 Dec 01; 17(12). PMID: 34844516    Free PMC article.
A novel mouse strain optimized for chronic human antibody administration.
Aaron Gupta, Patrick Smith, Stylianos Bournazos, Jeffrey V Ravetch.
Proc Natl Acad Sci U S A, 2022 Mar 03; 119(10). PMID: 35235456    Free PMC article.
A roadmap for translational cancer glycoimmunology at single cell resolution.
Andreia Peixoto, Andreia Miranda, Lúcio Lara Santos, José Alexandre Ferreira.
J Exp Clin Cancer Res, 2022 Apr 17; 41(1). PMID: 35428302    Free PMC article.
Altered glycosylation in pancreatic cancer and beyond.
Jan C Lumibao, Jacob R Tremblay, Jasper Hsu, Dannielle D Engle.
J Exp Med, 2022 May 07; 219(6). PMID: 35522218    Free PMC article.